Cargando…
Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review
BACKGROUND AND OBJECTIVE: The prognostic value of age and other non-hematological factors in predicting outcomes in older patients with newly diagnosed acute myeloid leukemia (AML) undergoing antileukemic therapy is not well understood. We performed a systematic review to determine the association b...
Autores principales: | Hao, Qiukui, Foroutan, Farid, Han, Mi Ah, Devji, Tahira, Nampo, Fernando Kenji, Mukherjee, Sudipto, Alibhai, Shabbir M. H., Rosko, Ashley, Sekeres, Mikkael A., Guyatt, Gordon H., Brignardello-Petersen, Romina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721486/ https://www.ncbi.nlm.nih.gov/pubmed/36469519 http://dx.doi.org/10.1371/journal.pone.0278578 |
Ejemplares similares
-
Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis
por: Colunga-Lozano, Luis Enrique, et al.
Publicado: (2022) -
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review
por: Chang, Yaping, et al.
Publicado: (2021) -
Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations
por: Devji, Tahira, et al.
Publicado: (2017) -
Living cumulative network meta-analysis to reduce waste in research: A paradigmatic shift for systematic reviews?
por: Vandvik, Per Olav, et al.
Publicado: (2016) -
When applying GRADE, how do we decide the target of certainty of evidence rating?
por: Zeng, Linan, et al.
Publicado: (2021)